4 Questions 5 Answers 0 Followers
Questions related from Nirmal Kumar
21 CFR Part 211 of US describes the 'Current Good Manufacturing Practices (cGMP)' for pharmaceutical industry. This is deemed to be dynamic, so that updated principles can be facilitated for...
21 October 2019 8,393 2 View
Several reports related to African and Asian countries mention that the menace of counterfeit pharmaceutical products is a global menace. This information is based on effective measure to...
29 July 2019 2,879 1 View
The counterfeit medicines is a global problem, irrespective of the nation and USFDA is not an exception. Shall appreciate comments from scholars about the steps taken by USFDA to control this menace.
01 January 1970 1,602 0 View
Quality of products or services is an essential requirement of consumers ! However, a corporate house who do not bother to maintain quality tend to decline due to loss of reputation and/or...
01 January 1970 6,001 3 View
